Highlights

  • Beamtree Holdings shares surged 31.58% on 15 June 2026, after the company appointed Gareth Pye as Chief Executive Officer, effective 13 July 2026.
  • Pye brings more than 18 years of experience from enterprise software company TechnologyOne.
  • The Board said the appointment follows an extensive international search process.
  • Beamtree is seeking to strengthen commercial execution, operational performance and product-market alignment as it enters its next phase.
  • The company also announced board committee leadership changes and upcoming director retirements.

Beamtree Holdings Ltd (ASX:BMT) shares climbed 31.58% to AUD 0.12 during morning trade on 15 June 2026 after the healthcare technology company announced the appointment of Gareth Pye as its new Chief Executive Officer.

The market reaction came after Beamtree unveiled a leadership transition that management described as an important step in the company's next stage of development. The appointment follows a comprehensive international executive search and is accompanied by broader board and governance changes designed to support the company's strategic priorities.

Despite today's sharp rally, Beamtree shares remain down 58.33% over the past 12 months, highlighting the challenges the company has faced during the period.

About Beamtree Holdings

Beamtree operates in the healthcare technology sector, providing software and technology solutions aimed at supporting healthcare organisations in improving performance, decision-making and patient outcomes.

The company has developed a portfolio of healthcare-focused technology products and research and development initiatives designed to assist healthcare providers with data-driven decision-making and operational efficiency.

In recent years, Beamtree has expanded its international presence, pursuing opportunities across several overseas markets, including the United Kingdom, Canada and Saudi Arabia. As the company seeks to broaden its commercial footprint, management has emphasised the importance of aligning product innovation with sustainable business performance.

The latest leadership announcement comes as Beamtree seeks to translate its technology capabilities and development efforts into long-term commercial outcomes.

Experienced Technology Executive Selected After Global Search

The centrepiece of today's announcement was the appointment of Gareth Pye as Chief Executive Officer, with the role becoming effective from 13 July 2026.

According to the company, the Board conducted an extensive international recruitment process before selecting Pye to lead the next phase of the business.

Pye joins Beamtree from TechnologyOne, one of Australia's established enterprise software companies, where he accumulated more than 18 years of experience across a range of senior executive positions.

His previous responsibilities included serving as Chief Financial Officer, Head of Strategy and Head of Product for TechnologyOne's Financials division.

The Board highlighted the combination of product leadership, strategic planning, financial management and commercial execution experience as key factors behind the appointment.

The company believes this mix of skills will support efforts to sharpen strategic priorities, strengthen operational delivery and improve the commercialisation of Beamtree's healthcare technology offerings.

Focus on Execution and Commercial Outcomes

A recurring theme throughout the announcement was the company's focus on improving execution and ensuring closer alignment between product development and commercial objectives.

Beamtree noted that it has reached a stage where the quality of its technology and research and development activities needs to be supported by stronger operational performance and increased commercial focus.

Management indicated that Pye's background in scaling enterprise software businesses and bringing products to market was viewed as particularly relevant as the company seeks to advance its growth strategy.

The company specifically referenced his experience in streamlining operations, improving accountability and aligning teams around clearly defined priorities.

These capabilities are expected to play a role in Beamtree's efforts to enhance organisational effectiveness while pursuing opportunities within the healthcare technology sector.

Incoming CEO Outlines Priorities

Following the announcement, Pye outlined several areas of focus for his tenure as Chief Executive Officer.

He noted that Beamtree possesses established products, experienced personnel and opportunities to support healthcare organisations through technology solutions designed to improve performance and outcomes.

According to Pye, his priorities will include strengthening operational execution, ensuring product and commercial strategies are aligned and positioning the business to pursue sustainable growth opportunities.

His comments indicate an emphasis on balancing innovation and product development with commercial discipline and business performance.

The appointment therefore represents not only a leadership transition but also a broader strategic focus on execution and organisational alignment.

Board Signals Next Stage of Company Development

Beamtree Chair Emma Gray described the appointment as an important step in the company's evolution.

The Board stated that it was seeking a leader capable of guiding the organisation through a phase characterised by greater accountability, disciplined growth and stronger commercial focus.

Management indicated that Pye's experience operating at senior levels within a large software company provided confidence in his ability to support these objectives.

The Board also highlighted his track record across product leadership, financial management and operational execution as qualities aligned with the company's strategic priorities.

According to the company, the search process focused on identifying a leader capable of simplifying organisational structures, improving accountability and helping Beamtree capitalise on opportunities within healthcare technology markets.

International Growth Initiatives Continue

While announcing the leadership transition, Beamtree also acknowledged the contribution of outgoing CEO Marek Stepniak.

The company credited Stepniak with helping develop a significant international pipeline, particularly across the United Kingdom, Canada and Saudi Arabia.

Importantly, Stepniak will remain with the business as Head of International until at least the end of 2026.

This arrangement is expected to provide continuity for ongoing international initiatives while allowing the incoming Chief Executive Officer to focus on broader organisational priorities.

The retention of leadership involvement in international operations may also support the transition process as Beamtree continues pursuing opportunities across overseas markets.

Board and Governance Changes Announced

Alongside the CEO appointment, Beamtree announced several board-related changes that will take effect over the coming weeks.

Directors Jim Birch AM and Brad Lancken will retire from the Board effective 30 June 2026.

The company also outlined committee leadership transitions.

Martin Bowles AO PSM, who recently stepped down as Chief Executive Officer of Calvary Health Care and joined the Beamtree Board in March 2026, will assume the role of Chair of the Audit and Risk Committee.

Meanwhile, Stuart MacDonald, Chief Operating Officer of TechnologyOne and a Beamtree director since October 2025, will become Chair of the Remuneration and Nomination Committee effective 30 June 2026.

These governance changes form part of the broader leadership transition announced by the company.

CEO Employment Package Disclosed

As required under ASX listing rules, Beamtree also disclosed key terms associated with Pye's employment agreement.

Under the arrangement, the incoming CEO will receive a fixed annual salary of AUD 450,000.

In addition, he will be eligible for a target short-term incentive of AUD 150,000, subject to the achievement of key performance indicators agreed with the Board for each financial year.

The company will also issue AUD 100,000 worth of fully paid ordinary Beamtree shares as a one-off sign-on grant.

For FY27, Pye will be granted a long-term incentive with a target value of AUD 250,000.

What This Means for Investors

Today's share price reaction suggests investors responded favourably to Beamtree's leadership announcement and the Board's stated focus on improving execution, accountability and commercial performance.

The appointment of a technology executive with extensive enterprise software experience comes as Beamtree seeks to strengthen the connection between its product development activities and long-term business outcomes.

Alongside the CEO transition, governance changes and the retention of international leadership responsibilities indicate a broader organisational refresh.

While today's announcement does not include financial guidance or operational updates, investors appear to be focusing on the strategic significance of the leadership changes and the company's efforts to position itself for its next stage of development.